Skip to main content
BCWORLDPHARM Co., Ltd. logo

BCWORLDPHARM Co., Ltd. — Investor Relations & Filings

Ticker · 200780 ISIN · KR7200780005 KO Manufacturing
Filings indexed 192 across all filing types
Latest filing 2020-02-28 Management Reports
Country KR South Korea
Listing KO 200780

About BCWORLDPHARM Co., Ltd.

https://www.bcwp.co.kr

BCWORLDPHARM Co., Ltd. is a technology-driven pharmaceutical company specializing in the research, development, and manufacturing of prescription drugs. The company leverages its core expertise in formulation and process development to produce a diverse portfolio of quality generic medicines. With a significant commitment to research and development, BCWORLDPHARM focuses on creating next-generation pharmaceuticals to address evolving medical needs and improve patient health outcomes.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports Classification · 95% confidence The document is a regulatory filing from a Korean company (BC World Pharm) disclosing a significant change in financial results (revenue or profit/loss structure change of 30% or more). This is a standard regulatory disclosure requirement in the Korean market (KRX) for listed companies to report material financial fluctuations before the final audit is completed. Since it provides specific financial highlights and reasons for the change rather than just announcing the availability of a report, it falls under the category of general regulatory filings.
2020-02-28 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for BC World Pharm. It outlines the date, location, and agenda items (financial statements, director appointments, etc.) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of the meeting and request their participation/votes, which falls under the Proxy Solicitation & Information Statement category.
2020-02-28 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for BC World Pharm. It contains the agenda for the 40th Annual General Meeting, including reports on business, audit, internal accounting, and proposals for financial statement approval, director appointments, and remuneration limits. It also includes detailed financial statements (balance sheet, income statement, etc.) as part of the meeting materials. This document is a standard Proxy Solicitation & Information Statement (PSI) provided to shareholders to inform them of meeting details and request their votes.
2020-02-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details changes in share ownership by major shareholders and special related parties (in this case, the departure of an executive, Seo Hye-ran). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-01-02 Korean
배당락(주식배당)
Notice of Dividend Amount Classification · 98% confidence The document is a short announcement regarding '배당락' (ex-dividend date) for BC World Pharm. It specifies the ex-dividend date, the reason (stock dividend), and the reference price. It does not contain the full financial report or dividend policy details, but rather serves as a specific notice of a corporate action event. Given the nature of the announcement regarding dividend mechanics, it fits best under the dividend notification category.
2019-12-26 Korean
주식배당결정
Notice of Dividend Amount Classification · 100% confidence The document is an official announcement from BC World Pharm regarding a decision to issue stock dividends. It details the number of shares per dividend, the total number of shares to be issued, the record date, and the board resolution date. This falls under the category of dividend announcements, which is specifically covered by the 'DIV' code.
2019-12-18 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.